{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:42:27Z","timestamp":1789155747172,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The apnea test (AT) plays a vital role in diagnosing brain death by evaluating the absence of spontaneous respiratory activity. It entails disconnecting the patient from mechanical ventilation to raise the CO<jats:sub>2<\/jats:sub> partial pressure and lower the pH. Occasionally, the AT is aborted because of safety concerns, such as hypoxemia and hemodynamic instability, to prevent worsening conditions. However, the exact oxygen partial pressure level needed before commencing AT, indicating an inability to tolerate the test, is still uncertain. This study seeks to determine pre-AT oxygen levels linked with a heightened risk of test failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a retrospective cohort study involving patients suspected of having brain death at the Tel Aviv Medical Center from 2010 to 2022. The primary outcome was defined as an arterial partial O<jats:sub>2<\/jats:sub> pressure (PaO<jats:sub>2<\/jats:sub>) level of 60\u00a0mmHg or lower at the conclusion of the AT. This threshold is significant because it marks the point at which the saturation curve deflects, potentially leading to rapid deterioration in the patient\u2019s oxygen saturation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 70 patients who underwent AT, 7 patients met the primary diagnostic criteria. Patients with a PaO<jats:sub>2<\/jats:sub>\u2009\u2264\u200960\u00a0mmHg at the conclusion of the AT exhibited a significantly lower initial median PaO<jats:sub>2<\/jats:sub> of 243.7 mmHg compared with those with higher pre-AT PaO<jats:sub>2<\/jats:sub> levels of 374.8 mmHg (interquartile range 104.65\u2013307.00 and interquartile range 267.8\u2013444.9 respectively, <jats:italic>P<\/jats:italic> value\u2009=\u20090.0041). Pre-AT PaO<jats:sub>2<\/jats:sub> levels demonstrated good discriminatory ability for low PaO<jats:sub>2<\/jats:sub> levels according to the receiver operating characteristic (ROC) curve, with an area under the curve of 0.76 (95% confidence interval 0.52\u20130.99).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>PaO<jats:sub>2<\/jats:sub> values at the conclusion of the AT are closely associated with PaO<jats:sub>2<\/jats:sub> values at the beginning of the test. Establishing a cutoff value of approximately 300\u00a0mmHg PaO<jats:sub>2<\/jats:sub> at the onset of AT may assist in avoiding saturation drops below 90%.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12028-024-02105-z","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T06:02:30Z","timestamp":1727157750000},"page":"450-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictive Hypoxemic Threshold for Tolerating the Apnea Test While Assessing Death by Neurological Criteria"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4327-8154","authenticated-orcid":false,"given":"Daniel","family":"Aviram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hikri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Aharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Galoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Lichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Goder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaph","family":"Nini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimrod","family":"Adi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekel","family":"Stavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"2105_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jcrc.2014.04.015","volume":"29","author":"MA De Georgia","year":"2014","unstructured":"De Georgia MA. History of brain death as death: 1968 to the present. J Crit Care. 2014;29:673\u20138.","journal-title":"J Crit Care"},{"issue":"3","key":"2105_CR2","first-page":"308","volume":"76","author":"DA Shewmon","year":"2011","unstructured":"Shewmon DA, Sylmar CA, Verheijde JL, Rady MY. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2011;76(3):308.","journal-title":"Neurology"},{"key":"2105_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207740","author":"DM Greer","year":"2023","unstructured":"Greer DM, Kirschen MP, Lewis A, Gronseth GS, Rae-Grant A, Ashwal S, et al. Pediatric and adult brain death\/death by neurologic criteria consensus guideline. Neurology. 2023. https:\/\/doi.org\/10.1212\/WNL.0000000000207740.","journal-title":"Neurology"},{"key":"2105_CR4","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1212\/WNL.0b013e3181e242a8","volume":"74","author":"EFM Wijdicks","year":"2010","unstructured":"Wijdicks EFM, Varelas PN, Gronseth GS, Greer DM. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:1911\u20138.","journal-title":"Neurology"},{"key":"2105_CR5","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1097\/01.CCM.0000090869.19410.3C","volume":"31","author":"RD Truog","year":"2003","unstructured":"Truog RD, Robinson WM. Role of brain death and the dead-donor rule in the ethics of organ transplantation. Crit Care Med. 2003;31:2391\u20136.","journal-title":"Crit Care Med"},{"key":"2105_CR6","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200189","volume":"13","author":"A Lewis","year":"2023","unstructured":"Lewis A, Kirschen MP, Greer D. The 2023 AAN\/AAP\/CNS\/SCCM pediatric and adult brain death\/death by neurologic criteria consensus practice guideline: a comparison with the 2010 and 2011 guidelines. Neurol Clin Pract. 2023;13: e200189.","journal-title":"Neurol Clin Pract"},{"key":"2105_CR7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jama.2020.11586","volume":"324","author":"DM Greer","year":"2020","unstructured":"Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, et al. Determination of brain death\/death by neurologic criteria: the World Brain Death Project. JAMA. 2020;324:1078\u201397.","journal-title":"JAMA"},{"key":"2105_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/0885066613511053","volume":"30","author":"IM Spinello","year":"2015","unstructured":"Spinello IM. Brain death determination. J Intensive Care Med. 2015;30:326\u201337.","journal-title":"J Intensive Care Med"},{"key":"2105_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/PCC.0000000000003198","volume":"24","author":"WN Sveen","year":"2023","unstructured":"Sveen WN, Antommaria AHM, Gilene SJ, Stalets EL. Adverse events during apnea testing for the determination of death by neurologic criteria: a single-center, retrospective pediatric cohort. Pediatr Crit Care Med. 2023;24:399\u2013405.","journal-title":"Pediatr Crit Care Med"},{"key":"2105_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5935\/0103-507X.20200069","volume":"32","author":"HE Sayan","year":"2020","unstructured":"Sayan HE. Retrospective analysis of the apnea test and ancillary test in determining brain death. Rev Bras Ter Intensiva. 2020;32:405\u201311.","journal-title":"Rev Bras Ter Intensiva"},{"key":"2105_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s12028-020-01015-0","volume":"34","author":"KM Busl","year":"2021","unstructured":"Busl KM, Lewis A, Varelas PN. Apnea testing for the determination of brain death: a systematic scoping review. Neurocrit Care. 2021;34:608\u201320.","journal-title":"Neurocrit Care"},{"key":"2105_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12028-010-9343-4","volume":"12","author":"AH Yee","year":"2010","unstructured":"Yee AH, Mandrekar J, Rabinstein AA, Wijdicks EFM. Predictors of apnea test failure during brain death determination. Neurocrit Care. 2010;12:352\u20135.","journal-title":"Neurocrit Care"},{"key":"2105_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.transproceed.2019.04.029","volume":"51","author":"JJ Kim","year":"2019","unstructured":"Kim JJ, Kim EY. Identification of hemodynamic risk factors for apnea test failure during brain death determination. Transplant Proc. 2019;51:1655\u201360.","journal-title":"Transplant Proc"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-02105-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-024-02105-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-02105-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T16:24:45Z","timestamp":1743351885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-024-02105-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2105"],"URL":"https:\/\/doi.org\/10.1007\/s12028-024-02105-z","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors has any conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"I confirm adherence to ethical guidelines and indicate ethical approvals (institutional review board) and use of informed consent, as appropriate. Retrospective studies require a statement regarding institutional review board approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}